$5.44
-0.57-9.48%
Ult. Agg.: Oct 23, 12:25 PM
CytoSorbents (CTSO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
CytoSorbents (CTSO) ha pubblicato l'ultima guidance il gennaio 12, 2026 per Q4 2025. La società ha previsto un fatturato pari a $9.2M - $9.2M per il periodo.
Rispetto alle previsioni precedenti, CytoSorbents {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
CytoSorbents ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il CytoSorbents. 4
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.80 | $-1.00 | $-1.00 | $-1.00 |
| Actual | $-1.40 | $-1.00 | $-1.40 | $-0.80 |
| Surprise | -75.0% | 0.00% | -40.0% | +20.0% |
| Revenue | ||||
| Estimate | $9.3M | $9.4M | $9.2M | $9.9M |
| Actual | $9.6M | $8.9M | $9.2M | $9.5M |
| Surprise | +3.04% | -5.35% | +0.27% | -4.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.90 | $-0.70 | $0.01 | $0.01 |
| Revenue | ||||
| Consensus | $9.9M | $10.5M | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.40 | $-0.80 | -75.0 % |
| Q1 | May 13, 2026 | $-1.00 | $-1.00 | 0.00 % |
| Q4 | Mar 25, 2026 | $-1.40 | $-1.00 | -40.0 % |
| Q3 | Nov 13, 2025 | $-0.80 | $-1.00 | 20.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $9.63M | $9.35M | 3.04 % |
| Q1 | May 13, 2026 | $8.86M | $9.36M | -5.35 % |
| Q4 | Mar 25, 2026 | $9.23M | $9.21M | 0.27 % |
| Q3 | Nov 13, 2025 | $9.49M | $9.94M | -4.61 % |